Revance Therapeutics | Crediti Commerciali



Trade Debtors Cambiamento Data
AbbVie USD 10.92B 553M 2024-12
ALKERMES USD 321.75M 72.97M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Eli Lilly USD 14B 727.8M 2025-03
J&J USD 16.02B 1.18B 2025-03
Merck USD 11.57B 452M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
P&G USD 6.14B 95M 2025-03
Pacira USD 104.74M 8.56M 2025-03
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12



Revance Therapeutics Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.